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Abstract
MHC class II (MHCII) genes are transactivated by the NOD-like receptor (NLR) family mem-
ber CIITA, which is recruited to SXY enhancers of MHCII promoters via a DNA-binding
“enhanceosome” complex. NLRC5, another NLR protein, was recently found to control tran-
scription of MHC class I (MHCI) genes. However, detailed understanding of NLRC5’s target
gene specificity and mechanism of action remained lacking. We performed ChIP-sequencing
experiments to gain comprehensive information on NLRC5-regulated genes. In addition to
classical MHCI genes, we exclusively identified novel targets encoding non-classical MHCI
molecules having important functions in immunity and tolerance. ChIP-sequencing performed
withRfx5−/− cells, which lack the pivotal enhanceosome factor RFX5, demonstrated its strict
requirement for NLRC5 recruitment. Accordingly,Rfx5-knockout mice phenocopyNlrc5 defi-
ciency with respect to defective MHCI expression. Analysis of B cell lines lacking RFX5,
RFXAP, or RFXANK further corroborated the importance of the enhanceosome for MHCI ex-
pression. Although recruited by common DNA-binding factors, CIITA and NLRC5 exhibit non-
redundant functions, shown here using double-deficientNlrc5−/−CIIta−/−mice. These para-
doxical findings were resolved by using a “de novo”motif-discovery approach showing that
the SXY consensus sequence occupied by NLRC5 in vivo diverges significantly from that oc-
cupied by CIITA. These sequence differences were sufficient to determine preferential occu-
pation and transactivation by NLRC5 or CIITA, respectively, and the S box was found to be
the essential feature conferring NLRC5 specificity. These results broaden our knowledge on
the transcriptional activities of NLRC5 and CIITA, revealing their dependence on shared
enhanceosome factors but their recruitment to distinct enhancer motifs in vivo. Furthermore,
we demonstrated selectivity of NLRC5 for genes encoding MHCI or related proteins, render-
ing it an attractive target for therapeutic intervention. NLRC5 and CIITA thus emerge as para-
digms for a novel class of transcriptional regulators dedicated for transactivating extremely
few, phylogenetically related genes.
PLOS Genetics | DOI:10.1371/journal.pgen.1005088 March 26, 2015 1 / 22
OPEN ACCESS
Citation: Ludigs K, Seguín-Estévez Q, Lemeille S,
Ferrero I, Rota G, Chelbi S, et al. (2015) NLRC5
Exclusively Transactivates MHC Class I and Related
Genes through a Distinctive SXY Module. PLoS
Genet 11(3): e1005088. doi:10.1371/journal.
pgen.1005088
Editor: Christine A. Wells, The University of
Queensland, AUSTRALIA
Received: July 19, 2014
Accepted: February 23, 2015
Published: March 26, 2015
Copyright: © 2015 Ludigs et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Data are deposited on
the GEO database http://www.ncbi.nlm.nih.gov/geo/
(accession number GSE59092).
Funding: Studies in the group of GG are funded by
the Swiss National Science Foundation
(PP00P3_139094) and the European Research
Council (ERC-2012-StG310890). Studies in the group
of WR are funded by the Swiss National Science
Foundation (310030B_144085). The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Author Summary
Major histocompatibility complex class I (MHCI) molecules are central to immunity and
immunological disorders, and constitute a major obstacle in organ transplantation. It is
therefore vital to gain insight into the regulation of their expression. NLRC5 was recently
found to regulate MHCI gene transcription. However, we lack a thorough understanding
of its target gene specificity and mechanism of action. Our work addresses these questions,
delineating the unique consensus sequence required for NLRC5 recruitment and pinpoint-
ing conserved features conferring its specificity. Furthermore, through genome-wide anal-
yses, we confirm that NLRC5 regulates classical MHCI genes and identify novel target
genes, all encoding non-classical MHCI molecules exerting an array of functions in immu-
nity and tolerance. We thereby demonstrate that NLRC5 exclusively transactivates genes
of the MHCI pathway, rendering it an attractive target for future therapeutic intervention.
The most striking feature of NLRC5 is its restricted and highly focused transcriptional ac-
tivity, which has been described so far only for one related factor, CIITA. NLRC5 and
CIITA therefore emerge as prototypes for a novel kind of extremely specific transcription-
al regulator.
Introduction
Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) constitute a family
of innate immune receptors involved mainly in inflammatory responses and cell death. The
NLR family member CIITA instead functions as the master transcriptional regulator of major
histocompatibility complex (MHC) class II (MHCII) genes, and mutations in the CIITA gene
lead to severe immunodeficiency [1]. Recently, NLR caspase recruitment domain containing
protein 5 (NLRC5) was shown to regulate transcription of MHC class I (MHCI) genes, primar-
ily in lymphocytes, where it is highly expressed [2,3,4,5,6]. Overexpression of NLRC5 was ini-
tially found to increase mRNA levels for genes encoding human MHCI molecules and proteins
functioning in the MHCI-mediated antigen presentation pathway, including beta-2-microglo-
bulin (B2M), transporter associated with antigen processing 1 (TAP1) and the proteasome sub-
unit beta type-9 (PSMB9) [3]. Four independently generated Nlrc5-knockout mice
subsequently established that NLRC5 regulates the expression of B2m, Tap1, Psmb9, classical
MHCI genes (H2-K,H2-D), and the non-classical MHCI gene H2-M3 [2,4,5,7]. Finally, in vivo
promoter occupancy by NLRC5 was demonstrated only for humanHLA-A and HLA-B, and
mouse H2-K, H2-D, and B2m [2,3].
CIITA-dependent transactivation of MHCII genes requires the SXY motif, a conserved en-
hancer found in all MHCII promoters. DNA-binding factors recognizing this element form an
“enhanceosome” complex that serves as a platform for the recruitment of CIITA [1]. The X-
binding regulatory factor X (RFX) complex is essential for enhanceosome assembly and CIITA
recruitment. A similar SXY motif is found in MHCI gene promoters, together with more distal
regulatory elements, and has been implicated in NLRC5-mediated transactivation [8,9]. En-
forced expression of the RFX5, RFXAP, and RFXANK subunits of RFX potentiated
NLRC5-driven MHCI transcription, and interaction between NLRC5 and overexpressed
RFXANK was observed [8].
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The shared use of enhanceosome factors by CIITA and NLRC5 suggests that these NLRs
might fulfill partially redundant functions, a hypothesis that has not been tested in vivo. The
relevance of endogenous enhanceosome factors for NLRC5-mediated MHCI-transactivation
has also not been assessed. Furthermore, a comprehensive set of genes regulated directly by
NLRC5 has not been defined. Finally, most NLRC5 target genes are encoded within the MHCI
locus, raising the question of whether NLRC5 specifically regulates each one individually or if
it instead establishes an open chromatin conformation at the entire locus. To address these
questions we compared CIITA and NLRC5-regulated gene expression in various cell types
from Rfx5−/−, Nlrc5−/−, CIIta−/− and CIIta−/−Nlrc5−/−mice, as well as in CIITA and RFX-defi-
cient B cell lines, and screened for NLRC5 target genes by means of chromatin immunoprecipi-
tation sequencing (ChIP-seq) experiments performed with T cells from control, Nlrc5−/−, and
Rfx5−/−mice.
We found that NLRC5 is remarkably dedicated for a small set of related genes: it selectively
occupies the promoters of genes coding for MHCI or related proteins, and identified the non-
classical MHCI genesH2-Q4,H2-Q6/7, andH2-T10/22 as novel NLRC5-regulated genes. Anal-
ysis of NLRC5-binding in Rfx5-deficient cells demonstrated that Rfx5 is essential for promoter
occupancy by NLRC5. Data generated in B cell lines carrying mutations in RFX5, RFXAP, and
RFXANK also indicated a key requirement for the enhanceosome in MHCI transactivation.
However, despite their recruitment by common factors, analysis of single (CIIta−/−, Nlrc5−/−)
and double deficient (CIIta−/−Nlrc5−/−) mice revealed that CIITA and NLRC5 are highly specif-
ic for distinct sets of genes. Identification of the consensus sequence occupied in vivo by
NLRC5 highlighted unique features that were shown to be responsible for NLRC5 specificity.
Results
Nlrc5−/− and Rfx5−/−mice exhibit similar defects in MHCI expression
Rfx5-deficient mice were exploited to assess the role of the enhanceosome factor Rfx5 in MHCI
expression. Analysis of H2-K cell-surface expression by flow cytometry in various immune cell
subsets derived from Rfx5+/- and Rfx5−/− littermates demonstrated that Rfx5-deficiency led to a
strong decrease in MHCI expression on T cells, NK cells, and NKT cells, a marked reduction
on B cells, and a more modest decrease on dendritic cells (DCs) (Fig. 1A). A similar trend, albe-
it less strong, was observed for H2-D (Fig. 1B). This phenotype was strikingly similar to that of
Nlrc5-deficient cells (Fig. 1A and B). However, the defect in MHCI expression observed in the
absence of Rfx5 was always slightly less profound as compared to that in Nlrc5-deficient cells,
suggesting the existence of mechanisms capable of compensating partially for the deficiency in
Rfx5.
We also measured MHCI mRNA expression by quantitative real-time RT-PCR (qRT-PCR)
in in vitro-generated B cell mutants and B cell lines derived from bare lymphocyte syndrome
(BLS) patients carrying inactivating mutations in CIITA, RFX5, RFXAP, and RFXANK. These
experiments underlined the importance of RFX factors for MHCI expression (Fig. 1C) [10,11].
Collectively, these results support a role for the enhanceosome in the recruitment and tran-
scriptional activity of NLRC5, in both human and mouse cells.
NLRC5 and CIITA have non-redundant functions
The fact that both NLRC5 and CIITA dock to similar SXY modules via shared enhanceosome
factors raised the question of whether or not these two NLRs are overlapping in their transacti-
vation role. That the two factors might exhibit partial redundancy in MHCI-transactivation
was suggested by the findings that decreased MHCI expression caused by NLRC5-deficiency is
more pronounced in T, NK, and NKT lymphocytes, which do not express CIITA, than in
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antigen-presenting cells (APCs) and thymic epithelial cells (TECs) [2], which express high lev-
els of CIITA. Previous studies had also suggested that CIITA can stimulate MHCI transcription
[10,11] and that MHCI promoters are occupied by CIITA in APCs [12,13]. We therefore gen-
erated double-deficient Nlrc5−/−CIIta−/−mice, and studied MHC expression in different im-
mune cell subsets by flow cytometry. Concomitant ablation of Nlrc5 and CIIta did not
substantially reduce H2-K and H2-D levels compared to single Nlrc5-deficiency, neither in any
hematopoietic cell type analyzed nor in medullary TECs (Figs. 2A and B, S1A and S1B), al-
though a minor but significant decrease was observed for H2-K in DCs. Accordingly, frequen-
cies of peripheral CD8+ T cells, which require MHCI for their development and maintenance,
were not decreased more strongly in Nlrc5−/−CIIta−/−mice than in Nlrc5−/−mice (S1C Fig.).
MHCII expression was not reduced further in APCs from double-knockout animals, being al-
ready at negligible levels in single CIIta-deficient cells (Fig. 2B). These data indicate that
NLRC5 and CIITA are highly specific for transactivating different sets of genes, even though
they rely on common DNA binding factors for their recruitment.
NLRC5 binds to promoters of known and newly identified MHCI genes in
an Rfx5-dependent manner
To gain a comprehensive view of genes regulated transcriptionally by NLRC5, we performed
ChIP-seq experiments in T cells, which express NLRC5 abundantly and exhibit a dramatic de-
fect in MHCI levels upon its ablation. Chromatin was extracted from T cells derived from con-
trol (WT and Nlrc5F/F), Nlrc5−/−, and Rfx5−/−mice. NLRC5-bound chromatin was enriched by
ChIP and submitted to deep sequencing.
Fig 1. MHCI expression is strongly reduced in Nlrc5−/− and Rfx5−/− lymphocytes. (A and B) MHCI expression on the indicated splenic cells was
analyzed inNlrc5F/F (n = 9), Nlrc5−/− (n = 9), Rfx5+/- (n = 10), and Rfx5−/− (n = 8) mice. Graphs illustrate geometric mean fluorescence intensities (MFIs) of
H2-K (A) and H2-D (B) for CD8+ T cells (gated as CD3+CD8+), CD4+ T cells (gated as CD3+CD4+), NK cells (gated as NK1.1+CD3-), NKT cells (gated as
NK1.1+CD3+), B cells (gated as CD19+), and DCs (gated as CD11chiCD11bint-hi). Results represent the mean ± SEM from two pooled experiments.
Statistical significance was calculated using an unpaired Student’s t-test, two-tailed; adjustment was made using a Bonferroni correction over 12 samples (A
and B). (C) HLA-A andHLA-CmRNAs were quantified by qRT-PCR inWT (Mann, HHK), CIITA-deficient (BLS2, RJ2.2.5), RFX5-deficient (Ro, SJO),
RFXANK-deficient (BLS1, Abdulla), and RFXAP-deficient (6.1.6, DA) B cell lines. Results were normalized using ACTB, expressed relative to Mann and
represent the mean ± SD derived from three independent experiments.
doi:10.1371/journal.pgen.1005088.g001
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As previously observed for CIITA [12], and in sharp contrast to most other transcription
factors, which typically occupy large numbers of sites in the genome [14], only a restricted
number of NLRC5-occupied sites were detected. A total of only 11 NLRC5-binding sites were
present in control (WT and/or Nlrc5F/F) cells but absent in Nlrc5−/− cells (Table 1, Figs. 3A, 4A,
S2A). Of the NLRC5-occupied sites, 9 resided in the vicinity (-500 to +50) of the transcription
Fig 2. NLRC5 and CIITA exhibit non-redundant functions. (A and B) MHCI and MHCII expression were
assessed in the indicated splenic cells from Nlrc5+/−CIIta+/−, Nlrc5−/−, CIIta−/−, andNlrc5−/−CIIta−/−mice.
Histogram overlays show H2-K or MHCII expression for control (dashed line), Nlrc5−/− (filled dark grey),
CIIta−/− (filled light grey), and double-deficient (solid line) mice. Graphs depict the MFIs of H2-K for CD8+ T
cells (gated as CD3+CD8+), CD4+ T cells (gated as CD3+CD4+), NK cells (gated as NK1.1+CD3-), and NKT
cells (gated as NK1.1+CD3+) (A), or B cells (gated as CD19+) and DCs (gated as CD11chiCD11bint-hi) (B) in
control (n = 9), Nlrc5−/− (n = 10), CIIta−/− (n = 9), and double-deficient (n = 8) mice (A and B). For B cells and
DCs, graphs also show the MFI of MHCII. MFIs of control mice were set at 100%. (A and B) Results depict the
mean ± SEM from three pooled experiments. Statistical significance of the differences between multiple
groups was analyzed by 2-way ANOVA adjusted by Bonferroni correction over 6 (H2-K) or 2 (MHCII)
samples, and is indicated only for differences between single and double-deficient groups (i.e., the interaction
between the two groups).
doi:10.1371/journal.pgen.1005088.g002
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start sites (TSSs) of 12 genes. The number of genes exceeds the number of peaks because 3
peaks lie between two closely spaced genes present in divergent orientations. Peaks at these
promoter sites were all absent in Rfx5−/− cells (Table 1, Figs. 3A, 4A, S2A). The remaining two
NLRC5-occupied sites were situated far from known promoters on chromosomes 1 and 15 and
were not Rfx5-dependent (Table 1).
Genes containing NLRC5-occupied sites in their promoter regions included genes previous-
ly suggested to be regulated by NLRC5 (H2-K, H2-D, B2m, Psmb9, and Tap1), validating the
quality of the ChIP-seq analysis (Table 1, Figs. 3A, S2A). In addition, novel target genes were
Table 1. NLRC5-occupied sites and target genes.
Gene Gene ID Peak
identiﬁcation
Peak
coordinates 1
TSS position
(orientation)
RFX5
dependent
ChIP
validation
Expression
validation
NLRC5
module
B2m ENSMUSG00000060802 peak calling chr2:122147175-
122148130
chr2:122147686
(+)
+ + + 3 +
H2-D1 ENSMUSG00000073411 peak calling chr17:35262463-
35263394
chr17:35262730
(+)
+ + + 3,4 +
H2-K1 ENSMUSG00000061232 peak calling chr17:34000049-
34000768
chr17:34000333
(-)
+ + + 3,4 +
H2-Q4 ENSMUSG00000035929 peak calling chr17:35379037-
35380004
chr17:35379617
(+)
+ + + 3 +
H2-Q6 ENSMUSG00000073409 peak calling chr17:35424724-
35424884
chr17:35424850
(+)
+ + + 4 +
H2-Q7 ENSMUSG00000060550 peak calling chr17:35438815-
35439225
chr17:35439155
(+)
+ + + 4 +
H2-T10 5 ENSMUSG00000079491 peak calling chr17:36121380-
36122293
chr17:36121465
(-)
+ + nd +
Gm19684
5
ENSMUSG00000092277 peak calling chr17:36121380-
36122293
chr17:36121678
(+)
+ + nd +
H2-T22 6 ENSMUSG00000056116 peak calling chr17:36042691-
36043453
chr17:36042747
(-)
+ + + 3 +
Gm6034 6 ENSMUSG00000073407 peak calling chr17:36042691-
36043453
chr17:36042961
(+)
+ + nd +
Tap1 7 ENSMUSG00000037321 peak calling chr17:34187312-
34187863
chr17:34187553
(+)
+ + + 3 +
Psmb9 7 ENSMUSG00000096727 peak calling chr17:34187312-
34187863
chr17:34187764
(-)
+ + + 3 +
H2-M3 ENSMUSG00000016206 visual 2 na chr17:37270220
(+)
+ nd + 3 -
Aida 8 ENSMUSG00000042901 peak calling chr1:183299156-
183299382
chr1:183297060
(+)
- nd nd -
Ly6c2 8 ENSMUSG00000022584 peak calling chr15:75085781-
75085890
chr15:75111584
(-)
- nd nd -
1 determined by peak calling
2 identiﬁed by visual inspection of ChIP-seq tracks
3 qRT-PCR
4
ﬂow cytometry
na not applicable
nd not determined
5 H2-T10 and Gm6034 share the same peak
6 H2-T22 and Gm19684 share the same peak
7 Tap1 and Psmb9 share the same peak
8 gene situated closest to peak
doi:10.1371/journal.pgen.1005088.t001
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identified (Table 1, Figs. 3A, 4A). Five of these are non-classical MHCI genes (H2-Q4,H2-Q6,
H2-Q7,H2-T10, and H2-T22). Two are predicted genes of unknown function (Gm19684,
Gm6034) situated in the reverse orientation immediately upstream of H2-T10 and H2-T22
(Fig. 3A and Table 1).
To ensure that the peak calling procedure had not missed binding sites in other MHC
genes, the entire MHC locus was scanned visually for potential binding sites. This identified
only one additional non-classical MHCI promoter (H2-M3) (Table 1). The latter was missed
by the peak-calling algorithm because of its low intensity. In contrast to CIITA [15], no
NLRC5-occupied intergenic enhancers were identified in the MHC locus.
Most NLRC5 targets were validated by classical quantitative ChIP experiments (Fig. 3B). To
investigate the relevance of NLRC5 and Rfx5 for transactivation of the target genes identified
Fig 3. Identification of NLRC5 targets. (A) NLRC5-ChIPseq tracks are shown for H2-D1, H2-T10/Gm19684 andGm11131/H2-Q4. The tracks depict reads
mapping to regions spanning between 5kb upstream and 5kb downstream of the peaks. After normalization as rpm (reads per millions), read coverage was
expressed relative to the maximal value observed in the region. TSSs are positioned as annotated in ENSEMBL (H2-T10, H2-Q4) or Refseq (H2-D1). (B)
Binding of NLRC5 was assessed by quantitative ChIP experiments performed with CD8+ T cells from Nlrc5F/F, Nlrc5−/−, Rfx5+/-, and Rfx5−/−mice. Results
are expressed relative to binding of NLRC5 to theH2-D promoter inNlrc5F/F cells, and depict the mean ± SD derived from three technical replicates and are
representative of two independent experiments. (C) mRNAs for the indicated genes were quantified relative to HprtmRNA in CD8+ T cells purified from a
pool of 4–5 mice of each indicated genotype. Values for Nlrc5−/− and Rfx5−/− cells are expressed as percentage of Nlrc5F/F and Rfx5+/-, respectively. Data
represent mean ± SD of technical triplicates, and are representative of at least two independent experiments. Statistical significance was calculated with an
unpaired Student’s t-test, two-tailed; adjustment was made using a Bonferroni correction over 2 samples. (D) MFI for Qa2 was analyzed in the indicated cell
subsets from Nlrc5F/F (n = 9), Nlrc5−/− (n = 9), Rfx5+/- (n = 10), and Rfx5−/− (n = 8) mice. Specific cell populations were gated on CD3+CD8+ for CD8+ T cells,
CD3+CD4+ for CD4+ T cells, NK1.1+CD3- for NK cells, NK1.1+CD3+ for NKT cells, CD19+ for B cells, and CD11chiCD11bint-hi for DCs. Results represent the
mean ± SEM derived from two pooled experiments. Statistical significance was calculated with an unpaired Student’s t-test, two-tailed; adjustment is made
using a Bonferroni correction over 12 samples.
doi:10.1371/journal.pgen.1005088.g003
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Fig 4. NLRC5 selectively occupies MHCI gene promoters. (A) NLRC5-ChIPseq tracks are shown for the
CIITA targetsH2-DMb1, H2-Aa and IncRNA/H2-Eb1. The tracks depict reads mapping to regions spanning
NLRC5 Regulates MHCI Genes through a Unique Motif
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by ChIP-seq, mRNA expression was quantified by qRT-PCR in control, Nlrc5−/−, and Rfx5−/−
CD8+ T cells (Fig. 3C). Transcript abundance of tested NLRC5 targets was reduced in the ab-
sence of either Nlrc5 or Rfx5, with the exception of Psmb9, whose expression was not altered in
the absence of Rfx5. High homology among non-classical MHCI genes did not allow quantifi-
cation ofH2-T10,H2-Q6, andH2-Q7 by qRT-PCR. However, we measured expression of the
Qa2 antigen (encompassing H2-Q6/7/8/9) by flow cytometry and observed a virtually com-
plete loss in all tested cell types in the absence of Nlrc5 or Rfx5 (Fig. 3D). Collectively, these re-
sults provide evidence for the critical importance of Rfx5 in recruiting NLRC5 and for the
contribution of the Rfx5-NLRC5 axis in activating most of the identified target genes.
NLRC5 and CIITA occupy distinct promoters
Although NLRC5 and CIITA are recruited by common enhanceosome factors, NLRC5-bind-
ing was not observed at the promoters of any MHCII genes (Fig. 4A). As the ChIP-sequencing
was performed in T lymphocytes, which do not express MHCII genes, we reasoned that an in-
accessible chromatin conformation might prevent NLRC5-binding to MHCII promoters in
these cells. We therefore immunoprecipitated NLRC5 and CIITA bound chromatin from con-
trol, Nlrc5−/−, CIIta−/−, and Nlrc5−/−CIIta−/− B cells, which express high levels of CIITA and
MHCII. Quantitative ChIP analysis confirmed that NLRC5 binding was observed at classical
and non-classical MHCI promoters but not at the prototypicalH2-EMHCII promoter
(Fig. 4B). As in T cells, NLRC5 recruitment was dependent on Rfx5 in B cells (S2B Fig.). CIITA
binding was evident at the H2-E promoter but not at any of the NLRC5 targets tested (Fig. 4B).
These results are consistent with our MHC expression data showing non-redundant functions
of NLRC5 and CIITA (Fig. 2).
These results emphasize the striking specificity of NLRC5 and CIITA for phylogenetically
related but distinct sets of genes (Fig. 4C). Interestingly, NLRC5-controlled genes encode clas-
sical and evolutionarily “middle-aged” and “young” non-classical MHCI molecules [16], with
the exception of B2m, which clusters together with MHCII molecules. This suggests that diver-
gent evolution underlies the differentiation of NLRC5 function and specificity.
Identification of a unique consensus motif for NLRC5 binding
A consensus sequence motif with similarity to the X box (Fig. 5A) was derived from promoter-
associated NLRC5-occupied sequences using an unbiased motif discovery approach. As orga-
nization of the S, X, and Y elements in human MHCII promoters is tightly constrained with re-
spect to their spacing [15,17], we searched for S and Y motifs located at the expected distance
ranges from the X box (Fig. 5A). For most NLRC5 targets, we identified S and Y elements situ-
ated at distances within 16 and 20–22 base pairs, respectively, from the X box (Figs. 5A, S3, and
S4A). Y motifs were not found at 20–22 base-pair distances from the X box in theH2-T10 and
H2-T22 promoters. We therefore performed a less stringent search for S and Y motifs situated
between 5kb upstream and 5kb downstream of the TSS. After normalization as rpm (reads per million), read
coverage was expressed relative to the average value observed for all NLRC5-binding peaks. TSSs are
positioned as annotated in ENSEMBL. (B) Antibodies specific for NLRC5 and CIITA were used to
immunoprecipitate cross-linked chromatin fragments derived from Nlrc5+/-CIIta+/-, Nlrc5−/−, CIIta−/−, and
Nlrc5−/−CIIta−/− B cells. Immunoprecipitates were analyzed by quantitative PCR for the abundance of
promoter sequences from the indicated genes. Relative promoter binding is shown. The average ± SEM of
three experiments are depicted. Statistical significance was calculated using an unpaired Student’s t-test. (C)
A phylogenetic tree is shown for classical and non-classical MHCI and MHCII genes. Genes regulated by
NLRC5 and those regulated by CIITA are indicated in blue and green font, respectively. Clusters of classical,
young and middle-aged MHCI genes are highlighted.
doi:10.1371/journal.pgen.1005088.g004
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at more variable distances upstream and downstream of the X box (S5 Fig.). This search re-
vealed the presence of Y motifs situated 48 base pairs downstream of the X box in the H2-T
promoters (Figs. 5A, S3, S4B, and S5). It also identified sequences exhibiting similarity to the S
box situated 45 base pairs upstream of the X box in these genes (S5 Fig.). Intriguingly, this
motif contains a Y sequence, which might influence expression ofH2-T10 andH2-T22 genes.
At all NLRC5 targets, the identified SXY modules were situated upstream of the TSS, near the
center of the NLRC5-binding peak (Fig. 5B).
Fig 5. Identification of a sequencemodule for selective NLRC5 recruitment. (A) Alignment of sequence
motifs situated within NLRC5-occupied peaks found in promoter regions of the indicated genes. S-X and X-Y
distance constraints used for identifying S and Y boxes were chosen such that these motifs should be
situated within 60 bp windows upstream or downstream of the center of the X box. Distances (bp) between
motifs are indicated. The sequence logo for the consensus NLRC5-module is shown below the alignment and
is compared with that previously defined for human CIITA. (B) NLRC5-binding peaks (blue boxes) were
oriented according to the direction of their SXY modules (red boxes). The 0 position on the x-axis
corresponds to the start of the X box. Peaks and modules are paired by their heights on the y-axis. Black
arrows represent TSS positions annotated in ENSEMBL. For two genes (H2-D and Psmb9) the predicted
TSSs from Refseq (red arrows) are shown because the TSSs annotated in ENSEMBL would be situated
upstream of the SXYmodule (see S2 Table).
doi:10.1371/journal.pgen.1005088.g005
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Irrespectively of the two approaches used for their identification, the SXY module defined
for NLRC5-binding diverges substantially from that observed for CIITA, particularly at the
level of the S box and at selected positions within the X box (Figs. 5A and S5).
A scan of the entire genome with the consensus motifs defined in Figs. 5A and S5 identified
15 and 173 putative matches, respectively. This indicates that spacing is a critical determinant
for NLRC5 binding (S4 Fig.), since relaxing the spacing constraint leads to a larger number of
predicted consensus sequences that are not actually occupied by NLRC5 (S4B Fig.). Among the
hits obtained with the more stringent screen, 11 were in found in the vicinity of TSSs (S1
Table). These matches corresponded to the promoter-associated NLRC5-occupied sites and no
MHCII genes or other CIITA-regulated genes were identified, underscoring the specificity of
the consensus motif for NLRC5-recruitment.
The S box sequence determines NLRC5-specific transactivation
To investigate whether differences between the SXY modules bound by NLRC5 and CIITA
were sufficient to confer transactivating specificity, we cloned the SXY regions of H2-K and
H2-Eb into reporter plasmids. These two SXY modules were chosen based on their high simi-
larity to the consensus motifs defined for NLRC5 and CIITA, respectively (Fig. 6A). NLRC5
Fig 6. The S box sequence is required for NLRC5-mediated transactivation. (A) Alignment of SXY regions ofH2-K andH2-Eb (H2-E). Bold letters
indicate the most conserved sequences in the S, X, and Ymotifs; boxes define the regions that were used to generate hybrid promoters 1–6 (see Material
and Methods) shown in C. (B) Luciferase reporter gene analyses were performed in HEK293T cells co-transfected with the H2-K or H2-Eb reporter
constructs and either empty vector (e.v.) or expression vectors encoding NLRC5 or CIITA. Data represent mean ± SD of technical triplicates expressed as
fold induction over e.v. and are representative of at least three experiments. Statistical significance was calculated using an unpaired Student’s t-test, two-
tailed. (C) Luciferase reporter gene analyses were performed in HEK293T cells co-transfected with empty or NLRC5-encoding expression vectors and the
WT (H2-K, H2-E) or hybrid (H2-K/E 1–6) promoter constructs depicted schematically below:H2-K andH2-Eb derived sequences are represented by blue
and green, respectively. Data are expressed as fold induction over e.v. and represent mean ± SEM of four independent experiments. Statistical significance
was calculated using an unpaired Student’s t-test, two-tailed.
doi:10.1371/journal.pgen.1005088.g006
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exclusively transactivated the H2-K construct, whereas CIITA preferentially activated the
H2-Eb construct (Fig. 6B). These results provided direct evidence that the SXY region dictates
the differential promoter specificities of NLRC5 and CIITA.
To pinpoint the elements conferring NLRC5 specificity, we generated a series of hybrid pro-
moters in which individual S, X, and Y boxes ofH2-K were replaced with the corresponding
ones fromH2-Eb and vice versa (Fig. 6C). Despite differences in the X box consensus sequences
defined for NLRC5 and CIITA (Fig. 5A), reporter assays performed with the hybrid promoters
indicated that the X boxes fromH2-K and H2-Eb were equally efficient at supporting
NLRC5-mediated transactivation (Fig. 6C). The Y box of H2-K partially contributed to NLRC5
activity but was not sufficient per se (Fig. 6C). In contrast, theH2-K S motif proved to be critical
for driving NLRC5-mediated activity, as its replacement with the S box of H2-Eb was sufficient
to abolish transactivation (Fig. 6C). Furthermore, this element was sufficient for promoting
NLRC5-induced transcription when placed into theH2-Eb reporter backbone (Fig. 6C). These
results show that the unique S box motif found in the promoters of NLRC5-regulated genes is
the major determinant for guiding selective gene activation by NLRC5.
Discussion
Our understanding of NLRC5’s function as a transcriptional regulator of MHCI genes has pro-
gressed rapidly during recent years; yet several fundamental aspects remained unexplored.
Here, we provide a comprehensive analysis of NLRC5-regulated genes in T cells, leading to the
identification of novel target genes and gaining new insights into the molecular mechanisms of
NLRC5 recruitment to specific promoters.
Interestingly, NLRC5-transactivated MHCI genes encode classical and evolutionarily “mid-
dle-aged” and “young” non-classical MHCI molecules, which generally support T cell receptor
engagement and NK cell inhibition [16]. The expression of non-classical MHCI molecules,
such as the novel target Qa2, have been shown to be important for the selection of non-conven-
tional T cell subsets and in the development of the preimplantation embryo [18,19,20].
H2-T10 and H2-T22 have been implicated in the selection of gamma-delta T cells with immu-
noregulatory functions [21,22]. Since the selection of unconventional T cell subsets is mainly
driven by hematopoietic cells, and could occur through T cell-T cell interactions, our data gen-
erated in T lymphocytes might be particularly relevant for this process [16,23,24]. Taken to-
gether, it appears that NLRC5 function has specifically co-evolved with the needs for MHCI-
restricted antigen-presentation to conventional or non-conventional T cell subsets, and with
NK cell education, suggesting the need to take a closer look at the role of NLRC5 in the devel-
opment of these subsets.
We provide evidence that Rfx5 serves as a key mediator of NLRC5 binding to the promoter
of its target genes, as its absence abolished NLRC5 recruitment to all target genes. Together
with evidence that RFX5, RFXAP and RFXANK contribute to HLA class I transcription in
human B cells, our findings unambiguously clarify the molecular nature of BLS type III disor-
ders, which are characterized by defects in both MHCI and MHCII expression [8,9,10,11].
Analysis of double-deficient mice demonstrated that CIITA and NLRC5 regulate distinct
sets of genes despite the fact that they use common enhanceosome factors and similar promot-
er sequences. This surprising situation raises the question as to how specificity is achieved.
ChIP-seq analysis allowed us to detail the preferential promoter module occupied by NLRC5.
Most prominently, selected positions within the X box and the remarkably conserved S
box emerged as key features associated with NLRC5 recruitment, thereby distinguishing the
SXY region recognized by NLRC5 from that occupied by CIITA. This is consistent with the re-
sults of reporter gene assays suggesting that the S box is required for NLRC5-mediated
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transactivation [8]. We demonstrate here that the distinctive S motif found in the promoters of
NLRC5-occupied genes is essential for conferring the transactivation specificity of NLRC5, and
that its replacement by the analogous S motif of CIITA-occupied promoters abrogates NLRC5
transactivation. This critical role of the S box suggests that the SXY module occupied by
NLRC5 promotes the assembly of an enhanceosome complex differing from that required for
the recruitment of CIITA, although the two complexes do share certain DNA-binding proteins.
In this respect it should be mentioned that the S box-binding factors remain to be identified
and could differ between NLRC5 and CIITA regulated genes.
Polymorphisms within the MHCI locus have been associated with infectious and autoim-
mune diseases. In many cases, the determining parameter is the MHCI haplotype, as different
alleles can present different peptide repertoires. However, it has recently been suggested that
various alleles can also be expressed at dissimilar levels, and that their abundance shows signifi-
cant associations with disease outcomes, as in the case of human immunodeficiency virus in-
fection and Crohn’s disease [25]. Given the fact that the SXY module is conserved between
mouse and humans [26], it will be important to establish whether promoter variants of alleles
associated with immunological disorders are differentially transactivated by NLRC5. Such cor-
relations could be of high medical relevance as predictive or prognostic markers in selected
immunological diseases.
The newly identified NLRC5 target genes encode non-classical MHCI molecules, emphasiz-
ing the remarkable selectivity of this NLR for regulating the MHCI system. This renders
NLRC5 an attractive candidate for therapeutic intervention aimed at modulating MHCI ex-
pression. The high specificity of NLRC5 for a small number of phylogenetically related MHCI
genes is strikingly similar to that of CIITA, for which ChIP-on-microarray experiments have
revealed high selectivity for genes involved in MHCII-mediated antigen presentation [12]. Al-
though recent ChIP-seq experiments have suggested that there are other CIITA-occupied sites
in the genome [27], their functional relevance remains to be demonstrated. The extremely fo-
cused activity of NLRC5 and CIITA sets them apart from other transcription factors and tran-
scriptional coactivators, which typically regulate hundreds or thousands of genes and exhibit
much more diverse and pleiotropic functions; these two NLRs are instead specialized for the
expression of only few phylogenetically and/or functionally related genes, representing a novel
type of highly dedicated transcriptional regulator.
Materials and Methods
Mice
Mice were treated in accordance with the Swiss Federal Veterinary Office guidelines. Nlrc5F/F,
Nlrc5−/− [2], CIIta−/− [28], and C57BL/6 control mice, all on a C57BL/6 (H2b) background,
were bred at the animal facility of the University of Lausanne. Nlrc5−/− and CIIta−/− were inter-
crossed to generate double-deficient animals. Rfx5−/− [29] and Rfx5+/- littermate controls on a
mixed Sv129/C57BL/6 (H2b) background were bred at the animal facility of the University of
Geneva Medical School. Sex and age-matched 6 to 12 week-old mice were used.
Cells and flow cytometry
Human BLS cell lines and in vitro generated B cell mutants have been described and are estab-
lished human cell lines [1,30]. T cells were enriched using anti-CD4 and/or anti-CD8 magnetic
beads (Miltenyi Biotec). For all flow cytometric analyses, gating on living cells and exclusion of
doublets was performed. Enriched TEC suspensions [2] were washed in PBS, 2% FCS, 5mM
EDTA and stained for flow cytometry using death exclusion markers (either DAPI or 7AAD),
UEA1 (Sigma) and the following mAb-conjugated mix: α-CD45 (30F11, BioLegend) and α-
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BP1 (6C3; BioLegend), α-MHCII (M5/114.15.2; eBioscience) and α-EpCAM (G8.8, Develop-
mental Studies Hybridoma Bank, Iowa), α-H2-Db (B22/24g) and α-H2-Kb (B8.24.3). Spleno-
cytes were preincubated with anti-CD16/32 (2.4G2) to block FcRs and stained using Abs
against CD8a (Ly-2), CD3e (145-2C11), CD4 (L3T4), CD11b (M1/70), CD11c (N418), CD19
(1D3), H2-Db (28-14-8), H2-Kb (AF6–88.5.5.3), MHCII (M5/114.15.2), NK1.1 (PK136), B220
(RA3-6B2), Qa-2 (69H1-9-9) (all from eBioscience). Streptavidin conjugated to different fluor-
ophores was from eBioscience. Stainings were performed with appropriate combinations of
fluorophores. Data was acquired with a FACSCanto flow cytometer (Becton Dickinson) and
analyzed using FlowJo software (Tree Star).
ChIP-sequencing
Chromatin was purified fromMACS-sorted WT (C57BL/6), Nlrc5F/F, Nlrc5−/−, and Rfx5−/− T
cells as described [31]. Five mice were pooled for each genotype. Chromatin immunoprecipita-
tion was performed using anti-NLRC5 antibody as described [2].
Immunoprecipitated DNA was sequenced using the Illumina HiSeq 2000 platform.>300
million reads were obtained for WT samples.>20 million reads were obtained for all other
samples. ChIP samples fromWT and Nlrc5F/F mice were used as biological repeats. Five pseu-
do-replicates of 30 million reads each were used for the WT data set, as proposed by the EN-
CODE consortium [32]. Reads were mapped to the mouse genome (release GRCm38.70) using
Bowtie 0.12.7 [33]. Only reads mapping to unique genomic positions were considered for
further analysis.
Fragment length was estimated using cross-correlation [32]. The Phantompeakqualtools
R package (https://www.encodeproject.org/search/?type=software&used_by=ENCODE&
software_type=quality%20metric) [32] was used to measure the quality of the ChIP-seq data,
as assessed by the normalized ratio between the fragment-length cross-correlation and the
background cross-correlation (normalized strand coefficient, NSC), the ratio between the frag-
ment-length peak and the read-length peak (relative strand correlation, RSC) and the Qtag
code. The low NSC scores obtained (< 1.05) (S6A Fig.) are a consequence of the low number
of peaks [32]. The RSC (> 1.51–1.85) and Qtag (2, high quality) scores obtained attest to the
quality of the ChIP-seq peaks (S6A Fig.) [32].
Peak calling for WT and Nlrc5F/F data sets was first done with MACS2 using the default set-
tings (q-value threshold of 0.05 and without the “–to-large” parameter). This led to the identifi-
cation of a surprisingly low number of reproducible peaks. The numbers of peaks were 6 and
11, respectively for the WT and Nlrc5F/F datasets. The low number of peaks called using the ini-
tial strategy prompted us to use second strategy based on using a lower peak calling stringency
followed by Irreproducible Discovery Rate (IDR) analysis. This was done to ascertain that that
the low number of peaks identified by our initial procedure was not in fact an artifact resulting
from overly-stringent peak selection. Peaks were called using MACS2 2.0.10.20130520 [34]
with no-model setting and shift-size parameter set to half of the estimated fragment length.
Peak calling stringency was decreased by using p = 0.001 as threshold and applying the “-to-
large” setting. Reads obtained from Nlrc5−/− samples were used as negative control for peak
calling. Reproducible peaks were obtained by assessing the IDR for all pairs of pseudo-repli-
cates using a threshold of 0.01 (S6B Fig.). Only 11 reproducible peaks were obtained, all of
which were confirmed in the biological repeat (Nlrc5F/F) but found to be absent in the Rfx5−/−
and Nlrc5−/− samples. These 11 peaks were the same as those identified in the Nlrc5F/F dataset
with the first peak identification strategy.
The Fraction of Reads in Peaks (FRiP) [32] was also calculated (S6C Fig.). The low FRiP val-
ues obtained (<1%) are consistent with the low number of peaks identified [32].
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Sequence analysis
For each gene, all annotated exons (release GRCm38.69) from all isoforms were used to create
a unique gene model in which all exons were merged into a single mRNA. The TSS of this
unique gene model was defined as the TSS for the corresponding gene. The promoter region
was defined as the region spanning −500bp to +50bp of the TSS. Peaks overlapping with pro-
moter regions were used for de novomotif discovery using the package cosmo [35] available
for the R project [36]. An initial search identified a motif corresponding to the previously pub-
lished X box [15]. Peaks were oriented relative to this X motif, and searches for S and Y motifs
were then performed within 60 (Figs. 5, S4A, S1 Table) or 100 (S5, S4B Figs.) base-pair win-
dows situated upstream and downstream of the center of the X box. This identified upstream
and downstream motifs corresponding, respectively, to the previously described S and Y boxes
[15]. Genome wide search for modules containing the 3 motifs was performed using both the
Position Weight Matrix (PWM) for each motif and the minimal and maximal distances be-
tween the motifs. The consensus for each motif was represented by a PWM obtained by align-
ing the sequences of the corresponding motif observed in peaks. The score of each sequence
versus its PWM was calculated for each peak, and 95% of this minimal score was used as
threshold for the genome wide search. Authorized spacing between the motifs in the genome
wide search was considered as that observed between the motifs found in peaks plus or minus
5nt. Only sequence modules containing the 3 motifs separated by the authorized distances
were accepted.
ChIP
Chromatin was purified as described [31] from Nlrc5F/F, Nlrc5−/−, Rfx5−/− and Rfx5+/-MACS-
sorted T cells (Fig. 3B, four to five mice were pooled per genotype), Nlrc5+/−CIIta+/−, Nlrc5−/−,
CIIta−/− and Nlrc5−/−CIIta−/− B cells (Fig. 4B, two mice were pooled per genotype), or WT
(C57BL/6), Nlrc5−/− and Rfx5−/− B cells (S2B Fig., four to five mice were pooled per genotype).
Chromatin immunoprecipitation was performed using anti-NLRC5 and anti-CIITA antibodies
as described [2,31]. Analysis of specific DNA regions was performed by qRT-PCR with the
primers shown in Table 2.
Table 2. Primers used for qRT-PCR analysis after ChIP
Mouse Gene Forward Reverse
H2-D CTTCTGCCGGGACACTGATGAC GCTGATTGGCTCCTGGAATCTC
H2-K TCACTTCTGCACCTAACC GGCTGCGTGGACTTTATATC
B2m TAGTAGGGCACCAAGGGTCCAG ACTCACAGCCAATCCGGACTC
H2-Q4 GGGTTCAGGCAAAGTCTTAG GTGAGAACTGCCAGTAAGTC
H2-Q6 AGGTGATCACCGGGAACC GCAAGAGCAGCGTTGTTAGA
H2-Q7 GCAGTGAGGTCAAGGGTAG GTGAGAACTGTTACACGTCA
H2-T10 CTGAGAGCCATTGCCTGGGA CTTCTGGAGGAGTCCTGTGT
H2-T22 GTCCTTGCCTGCCAGGGATT CAGACAGCCTCTGAACAGGT
Tap1 ATCACTCCACCCGCTGACTCTC CGCAGCCGCTGATTGGAAAG
H2-Eb1 AGCAGCCCAGACTGAGTATC GGGAGCCAATCAGCATCAAAG
TBP GCTTGCTTGGGCTTGATCG ACGGCCCTTTCTAGCTGTC
Baseline TCTCTGGGCAACCTTTGTTC CCCAGTCCTTTGGTTCTTTG
doi:10.1371/journal.pgen.1005088.t002
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Quantitative RT-PCR
Total RNA was extracted using the TriFastTM reagent according to manufacturer's instructions
(PEQLAB Biotechnologie). Retrotranscription to cDNA, quantification, and data analysis have
been described [37]. Expression was determined relative the indicated housekeeping gene.
Primer sequences used are listed in Table 3.
Phylogenetic tree of mouse MHCmolecules
The following amino-acid sequences were downloaded fromMGI (http://www.informatics.jax.
org/): H2-Ke2 (MGI:95908), H2-K1 (MGI:95904), H2-Ke6 (MGI:95911), H2-Oa
(MGI:95924), H2-DMa (MGI:95921), H2-DMb2 (MGI:95923), H2-DMb1 (MGI:95922),
H2-Ob (MGI:95925), H2-Ab1 (MGI:103070), H2-Aa (MGI:95895), H2-Eb1 (MGI:95901),
H2-Eb2 (MGI:95902), H2-D1 (MGI:95896), H2-Q1 (MGI:95928), H2-Q2 (MGI:95931),
H2-Q4 (MGI:95933), H2-Q6 (MGI:95935), H2-Q7 (MGI:95936), H2-Q10 (MGI:95929),
H2-T24 (MGI:95958), H2-T23 (MGI:95957), H2-T22 (MGI:95956), H2-T17 (MGI:95949),
H2-M10.1 (MGI:1276522), H2-T10 (MGI:95942), H2-T3 (MGI:95959), H2-M10.2
(MGI:1276525), H2-M10.4 (MGI:1276527), H2-M1 (MGI:95913), H2-M9 (MGI:1276570),
H2-M10.3 (MGI:1276524), H2-M11 (MGI:2676637), H2-M10.5 (MGI:1276526), H2-M5
(MGI:95917), H2-M3 (MGI:95915), H2-M2 (MGI:95914), Mill1 (MGI:2179988), Cd1d1
(MGI:107674), B2m (MGI:88127), Mr1 (MGI:1195463), Azgp1 (MGI:103163), Mill2
(MGI:2179989), Fcgrt (MGI:103017), Cd1d2 (MGI:107675), H2-Q8 (MGI:95937), H2-Q9
(MGI:95938) and H2-T9 (MGI:95965). Alignment was performed using the Muscle tool [38],
the best model to construct the phylogenetic tree was assessed using Prottest [39], and the phy-
logenetic tree was constructed in PhyML [40] using the JTT substitution model.
Luciferase reporter gene assays
Luciferase reporter plasmids were created by replacing the MluI—BglII fragment spanning the
HLA-DRA SXY region in the pDRAprox plasmid [15] with the corresponding H2-K, H2-Eb1
and hybrid SXY regions. The pGL3-min plasmid containing only the HLA-DRA core promoter
(from −60 to +10) in the same reporter plasmid was used as negative control. DNA fragments
corresponding to the SXY regions were generated using partially complementary primers that
were annealed and amplified by PCR using GoTaq polymerase (Promega). Primer sequences
Table 3. Primers used for qRT-PCR analysis
Human Gene Forward Reverse
HLA-C CAGAAGTACAAGCGCCAGG TAGGCGGACTGGTCATACC
HLA-A AAAAGGAGGGAGTTACACTCAGG GCTGTGAGGGACACATCAGAG
ACTB CTGGCACCCAGCACAATG GCCGATCCACACGGAGTACT
Mouse Gene Forward Reverse
H2-D ACCCAGGACATGGAGCTTGT GCTCCAAGGACACCCAGAAC
H2-K TTGAATGGGGAGGAGCTGAT GCCATGTTGGAGACAGTGGA
B2m CCTGGTCTTTCTGGTGCTTG TTCAGTATGTTCGGCTTCCC
Tap1 TACCCAAACCAGCCCAAAGT GGTGCTCTTCCCTGATCCAT
Lmp2 TGGTTATGTGGACGCAGCTT ACACCCCCACTAGAGCCATC
H2-T22 TCGCTCTAGTTTATAAAGCTGTCCAAG TGTAGAAATACCTAAGCGAGTGTGAAC
H2-Q4 AACAATGCTGCTTCTGCTGGT GTGAGACCCCGAACTCCTTC
H2-M3 CTCTTCATCCTTCTGCCAGG AGGAGATTCTTCAGCGAGCA
Hprt GCAGTACAGCCCCAAAATGG AACAAAGTCTGGCCTGTATCCAA
doi:10.1371/journal.pgen.1005088.t003
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used are listed below. Extensions containing the MluI and BglII restriction sites (underlined)
used for cloning are indicated in smaller font.
H2-K construct:
5’ATGCACGCGTCCACAGTTTCACTTCTGCACCTAACCTGGGT-
CAGGTCCTTCTGTCCGGACACTGTTG 3’ (forward primer)
5’TGGTAGATCTCGCCACCCAATGGGGGTAAGAGCTGACTGCGCGTCAA-
CAGTGTC 3’ (reverse primer)
H2-E construct:
5’ATGCACGCGTAACTGCAAGTTTCAGAAGGGGACCTGCAAACTGAATCTCTAAC-
TAGCAACTGATGA 3’ (forward primer)
5’TGGTAGATCTTGGGAGCCAATCAGCATCAAAGGAGTCCAGCATCATCAGTTG
3’ (reverse primer)
Hybrid H2-K/E construct 1:
5’ATGCACGCGTAACTGCAAGTTTCAGAAGGGGACCTGGGT-
CAGGTCCTTCTGTCCGG ACACTGTTG 3’ (forward primer)
5’TGGTAGATCTCGCCACCCAATGGGGGTAAGAGCTGACTGCGCGTCAA-
CAGTGTC 3’ (reverse primer)
Hybrid H2-K/E construct 2:
5’ATGCACGCGTCCACAGTTTCACTTCTGCACCTAACCTGGGTCAGGTCCTTCTGAC-
TAGCAACTGATGA 3’ (forward primer)
5’TGGTAGATCTCGCCACCCAATGGGGGTAAGAGCTGACTGCGCATCATCAGTTG
3’ (reverse primer)
Hybrid H2-K/E construct 3:
5’ATGCACGCGTCCACAGTTTCACTTCTGCACCTAACCTGGGT-
CAGGTCCTTCTGTCCGGACACTGTTG 3’ (forward primer)
5’TGGTAGATCTTGGGAGCCAATGGGGTAAGAGCTGACTGCGCGTCAA-
CAGTGTC3’ (reverse primer)
Hybrid H2-K/E construct 4:
5’ATGCACGCGTCCACAGTTTCACTTCTGCACCTAACCTGCAAACTGAATCTCTAAC-
TAGCAACTGATGA 3’ (forward primer)
5’TGGTAGATCTTGGGAGCCAATCAGCATCAAAGGAGTCCAGCATCATCAGTTG
3’ (reverse primer)
Hybrid H2-K/E construct 5:
5’ATGCACGCGTAACTGCAAGTTTCAGAAGGGGACCTGCAAACTGAATCTC-
TATCCGGACACTGTTG3’ (forward primer)
5’TGGTAGATCTTGGGAGCCAATCAGCATCAAAGGAGTCCAGCGTCAACAGTGTC
3’ (reverse primer)
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Hybrid H2-K/E construct 6:
5’ATGCACGCGTAACTGCAAGTTTCAGAAGGGGACCTGCAAACTGAATCTCTAAC-
TAGCAACTGATGA 3’ (forward primer)
5’TGGTAGATCTCGCCACCCAATGCAGCATCAAAGGAGTCCAGCATCATCAGTTG
3’ (reverse primer)
HEK293T cells were subconfluently seeded into a 96-well plate and co-transfected with
Polyfect reagent (Qiagen) following the manufacturer’s instructions with 25 ng of empty,
human NLRC5 or human CIITA (pIII) expression vectors and 25 ng of the indicated luciferase
reporter constructs [2]. 5 ng of Renilla luciferase vector were included for normalization. Cells
were harvested 22h post-transfection and cell lysates were analyzed using the Dual-Luciferase
Reporter Assay System (Promega) following the manufacturer’s instructions.
Statistical analysis
Statistical differences were calculated as described in the Figure legends. Differences were con-
sidered significant when p0.05 (), very significant when p0.01 () and extremely signifi-
cant when p0.001 ().
Ethics statement
Mice were treated in accordance with the Swiss Federal Veterinary Office guidelines. Human
cell lines are established cell lines.
Supporting Information
S1 Fig. T cell homeostasis and further analysis of the MHC phenotype in Nlrc5−/−, CIIta−/−
and Nlrc5−/−CIIta−/−mice. (A) Graphs depict the MFIs of H2-D for CD8+ T cells (gated as
CD3+CD8+), CD4+ T cells (gated as CD3+CD4+), NK cells (gated as NK1.1+CD3-), NKT cells
(gated as NK1.1+CD3+), B cells (gated as CD19+), and DCs (gated as CD11chiCD11bint-hi)
from control (n = 6), Nlrc5−/− (n = 6), CIIta−/− (n = 6) and double-deficient (n = 5) mice. Re-
sults depict the mean ± SEM from two pooled experiments, and are representative of three in-
dependent experiments. Differences among multiple groups were analyzed by 2-way ANOVA
adjusted by Bonferroni correction over 6 samples and are shown only for the effect double as
compared to single-deficiency. (B) MFIs for H2-K and H2-D expression by Nlrc5−/− (n = 4
mice), CIIta−/− (n = 4 mice), and Nlrc5−/−CIIta−/− (n = 4 mice) mTECs (gated as CD45−
UEA1+) are expressed as percentage of Nlrc5+/−CIIta+/− (n = 4 mice) control mice mTECs. Re-
sults represent the mean ± SEM derived from two pooled experiments, and are representative
of three independent experiments. The histogram overlay for MHCII expression shows a rep-
resentative mouse for each group. Differences among multiple groups were analyzed by 2-way
ANOVA and are shown only for the effect double as compared to single-deficiency. (C) Per-
centages and numbers of splenic CD8+ (gated as CD3+CD8+) and CD4+ T cells (gated as
CD3+CD4+) from control (n = 6), Nlrc5−/− (n = 6), CIIta−/− (n = 6) and Nlrc5−/−Ciita−/−
(n = 5) mice are shown. Results depict the mean ± SEM from two pooled experiments, and are
representative of three independent experiments.
(TIF)
S2 Fig. Characterization of NLRC5 targets. (A) NLRC5-ChIPseq tracks are shown for the
NLRC5 targets B2m and Psmb9/Tap1. The tracks depict reads mapping to regions spanning
between 5kb upstream and 5kb downstream of the TSS. After normalization as rpm (reads per
million), read coverage was expressed relative to the maximal value observed in the region.
TSSs are positioned as annotated in Refseq (Psmb9) or ENSEMBL (others). (B) Antibodies
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specific for NLRC5 were used to immunoprecipitate cross-linked chromatin fragments derived
fromWT, Nlrc5−/− and Rfx5−/− B cells. Immunoprecipitates were analyzed by quantitative
PCR for the abundance of promoter sequences from the indicated genes. Relative promoter
binding is shown. Results represent the average ± SD of technical triplicates.
(TIF)
S3 Fig. Schematic alignment of the promoter regions of mouse NLRC5 target genes. Posi-
tions of the SXY modules and distal regulatory elements (interferon stimulation response ele-
ment (ISRE) and enhancer A) defined in classical MHCI promoters are indicted by colored
boxes. Predicted motifs were identified by homology searches on the basis the sequence of the
upper (boxes above line) and/or or lower (boxes below line) strands.
(TIF)
S4 Fig. Spacing requirements for the recruitment of NLRC5 to SXY sequence modules. S-X
and X-Y spacing distributions are shown for SXY modules occupied by NLRC5 (top graphs)
and all genomic matches to the SXY consensus module (bottom graphs) defined by two differ-
ent motif discovery approaches giving more (A, maximum 60 base pairs) or less (B, maximum
100 bp) weight to S-X and X-Y spacing. The percent of modules (Y axis) are plotted as a func-
tion of distance in base pairs (X axis) between the S and X motifs (red bars) or the X and Y mo-
tifs (blue bars). The S, X and Y sequence logos are shown below. The most prominent spacing
characteristic of NLRC5-occupied modules are indicated at the top and highlighted by red and
blue underlays.
(TIF)
S5 Fig. Identification of a consensus motif for NLRC5 recruitment using a less stringent
spacing constraint. Alignment of sequence motifs situated within NLRC5-occupied peaks
found in promoter regions of the indicated genes. S-X and X-Y distance constraints used for
identifying the S and Y motifs were set at a maximum of 100 base pairs for each. Distances (bp)
between motifs are indicated. The sequence logo for the consensus NLRC5-module is shown
below the alignment and is compared with that previously defined for human CIITA.
(TIF)
S6 Fig. ChIP-seq metrics. (A) Strand cross-correlation analysis was performed for 5 WT pseu-
do-replicates (A_WT, B_WT, C_WT, D_WT, E_WT), the complete WT dataset (All_WT),
and the Nlrc5F/F dataset. Peak heights corresponding to the average fragment size (dashed blue
lines) are markedly higher than peak heights corresponding to read length (first dashed red
lines to the right of the dashed blue lines). NSC, RSC, and Qtag values are indicated below each
graph. Low NSC values are expected due to the low number of peaks. RSC and Qtag values at-
test to the quality of the ChIP-seq peaks. (B) Irreproducible Discovery Rate (IDR) analysis on
pseudo-replicates. Coloured lines represent all pairwise comparisons between the 5 WT pseu-
do-repeats. Peaks were called with the MACS2 peak caller using p<0.001 and the “–to-large”
setting. Numbers of called peaks before IDR analyses were 459, 529, 1436, 1043 and 1207 re-
spectively. The IDR threshold was set at 0.01. (C) Fraction of Reads in Peaks (FRiP) values. Left
panel: FRiP values are represented for eachWT pseudo-replicate, before and after IDR analysis.
Numbers of peaks called in each pseudo-replicate before IDR analyses were as in B. The num-
ber of final peaks (after IDR analysis) was 11. Right panel: FRiP values are shown for each pseu-
do-replicate and the original WT data set when the peak calling procedure was performed
using the default parameters of MACS2. Numbers of called peaks were 11, 11, 11, 11, 10 and 6
for the pseudo-replicates and the complete WT dataset, respectively. Low FRiP values are ex-
pected due to the low number of peaks.
(TIF)
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